Teva Pharmaceutical Industries (TEVA) Net Income (2016 - 2025)
Historic Net Income for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $690.0 million.
- Teva Pharmaceutical Industries' Net Income rose 35090.91% to $690.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 billion, marking a year-over-year increase of 25834.15%. This contributed to the annual value of $1.4 billion for FY2025, which is 17158.16% up from last year.
- Teva Pharmaceutical Industries' Net Income amounted to $690.0 million in Q4 2025, which was up 35090.91% from $432.0 million recorded in Q3 2025.
- Over the past 5 years, Teva Pharmaceutical Industries' Net Income peaked at $690.0 million during Q4 2025, and registered a low of -$1.8 billion during Q4 2023.
- Over the past 5 years, Teva Pharmaceutical Industries' median Net Income value was -$43.5 million (recorded in 2021), while the average stood at -$217.8 million.
- Its Net Income has fluctuated over the past 5 years, first tumbled by 128658.54% in 2022, then skyrocketed by 35090.91% in 2025.
- Over the past 5 years, Teva Pharmaceutical Industries' Net Income (Quarter) stood at -$151.0 million in 2021, then plummeted by 783.44% to -$1.3 billion in 2022, then crashed by 34.63% to -$1.8 billion in 2023, then soared by 84.69% to -$275.0 million in 2024, then surged by 350.91% to $690.0 million in 2025.
- Its Net Income was $690.0 million in Q4 2025, compared to $432.0 million in Q3 2025 and $281.0 million in Q2 2025.